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Neuropsychiatric complications of human immunodeficiency virus (HIV) infection or acquired immune deficiency
syndrome (AIDS) may present clinically as acute or chronic organic brain syndrome, or mimic functional psychiatric
diseases. Among such psychiatric diseases, mania tends to occur with increased frequency after the onset of AIDS.
We report a case in which manic manifestations were noted before the diagnosis of AIDS. The patient had no past
or family history of mood disorders, but had risk factors for HIV infection. He had a rapid downhill course from
initial manic symptoms to depression, dementia and then death within 10 months. Such rapid cognitive deterioration
into AIDS dementia after mania is consistent with previous reports. Cases like this will become more common with
spread of the AIDS pandemic in Asian regions, including Taiwan. Clinicians should be mindful of HIV infection/AIDS
as a differential diagnosis in patients with manic episodes and risk factors for HIV infection. [J Chin Med Assoc
2005;68(2):92–95]
Key Words: AIDS (acquired immune deficiency syndrome), bipolar mania, HIV (human immunodeficiency virus) infection
Introduction
Acquired immune deficiency syndrome (AIDS) is a
disease with various clinical manifestations that affects
the immune system and the entire human organism.
Central nervous system (CNS)-related manifestations
of human immunodeficiency virus (HIV) infection
include cognitive impairment, psychotic disorders,
mood disorders, CNS opportunistic infections, and
neoplasms.1–3 Some opportunistic infections and
neoplasms are becoming less common because of the
widespread use of highly active antiretroviral therapy
(HAART).4,5 Conversely, psychiatric disorders related
to HIV infection are becoming increasingly recognized.
Kilbourne et al surveyed psychiatric comorbidity
in 881 HIV-infected veterans and found 46% with
significant depressive symptoms, 21% with at-risk
drinking, 32% with anxiety, 4% with mania, 4% with
schizophrenia, and 11% with cognitive impairment.5
Patients with HIV infection or AIDS now live longer
because of treatment advances, but this presents a
longer period for psychiatric symptoms to develop.
Mental disturbances may influence treatment compli-
ance, quality of life, and risk behaviors for contracting
AIDS.6 In addition, patients might seek help for psy-
chiatric complaints earlier than for physical distress,
i.e. before the diagnosis of AIDS is made.7,8 We report
a case in which bipolar manifestations were noted
before the diagnosis of AIDS.
Case Report
A 37-year-old, divorced businessman presented to our
psychiatric outpatient clinic in September 1999 with a
1-month history of elated mood, decreased need for
sleep, ideas of grandeur, racing thoughts, hyperactivity,
and hypersexuality. No past history of psychiatric
disorders, substance abuse, or mood disorders related
to medical problems, was elicited. A family history of
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affective disorders, including bipolar disorder, was
also negative. An examination of mental status revealed
clear consciousness, with alertness and intact orienta-
tion. Other than distractibility, no other significant
cognitive deficits were noticed. The patient was irritable,
excited, grandiose, hypertalkative, and had flighty
ideas. He denied auditory or visual hallucinations, or
ideas of persecution or being followed. Concurrent
impairment of work, social function, and family life,
was also reported. Because of a suspected manic episode
of bipolar disorder, the patient was given valproic acid
400 mg twice daily and anxiolytic agents. Lithium
300 mg twice daily was added 2 weeks later due to
persistently elevated mood, and the patient’s manic
symptoms were rapidly controlled. Meanwhile, the
patient was also diagnosed with chronic bronchitis,
manifesting with long-term dry cough and chest
tightness; palliative therapy was given at a chest clinic.
The patient also complained of diarrhea and weakness
of the lower limbs after lithium administration. In
December 1999, he experienced a first episode of de-
pression. Sertraline 50 mg once daily was prescribed
along with supportive psychotherapy. His mood was
stabilized and depression dissipated, but left hand
tremor began to appear in January 2000. In the
following 2 months, the patient did not return to our
clinic. His family reported that 2 weeks before
admission, he gradually developed depression again,
with somnolence, memory impairment, and inability
to manage his daily life.
On March 26, 2000, the patient was brought to
our emergency unit with reported mental confusion,
disorientation, unsteady gait, intermittent fever, and
nystagmus, for 3 days. Lithium intoxication was initially
suspected and then ruled out given plasma lithium and
valproic acid levels of 0.35 mmol/L and 19.88 mg/L,
respectively. Brain computed tomography (CT) and
magnetic resonance imaging (MRI) disclosed
numerous nodular lesions of various sizes in both
cerebral hemispheres (including frontal and thalamic
areas, the right posterior parietal region, the caudate
head and lentiform nucleus), the brain stem, and
cerebellum. The lesions were associated with perifocal
edema and mass effects (Figure 1). The imaging
findings suggested diffuse CNS infection with cerebri-
tis and/or abscesses, indicating that he was immuno-
compromised; this clinical impression was subsequent-
ly confirmed by positive results of HIV ELISA and
Western blot examination. A medical history relating
to risk of HIV infection revealed that the patient had
stayed in Africa from 1989–1994. During that period,
he had malaria and potential sexual exposure to HIV
through a relationship with an African woman.
After admission to the infection unit, the patient’s
initial HIV viral load was 229,592 copies/mL, his
CD4 cell count was 34/mm3, and his T4/T8 cell rate
was inverted; Pneumocystis carinii pneumonia was
suspected from chest X-ray. These findings confirmed
the diagnosis of AIDS. The patient was then started on
HAART for HIV infection. However, the nature of
the diffuse nodular lesions remained undetermined
because of the absence of a brain biopsy and negative
results of cerebrospinal fluid culture. Because of the
clinical impression of CNS infection other than HIV
encephalopathy, and with differential diagnoses of
cryptococcosis, tuberculosis, toxoplasmosis, multicen-
tric glioma, cytomegalovirus encephalitis, and fungal
or parasitic infection, antibiotics were administered
and the acute distress stabilized. However, the patient
continued to have dementia with frequent myoclonic
seizures. A follow-up brain MRI scan after 2 months
showed evidence of abscess maturation and regression
of perifocal edema and mass effects. The patient’s to-
tal coma scale score was 8, with no improvement in
cognitive function. Although a follow-up brain MRI
scan after 4 months showed imaging evidence of
improved lesions (Figure 2), and although the HIV
viral load decreased to 1,491 copies/mL, the patient
died of respiratory failure 10 months after the initial
manic episode.
Figure 1. Initial magnetic resonance imaging scan of the brain.
(A) Three slices of T1-weighted trans-axial images with contrast-
agent injection showing multiple, faint, enhanced nodular lesions
of various sizes in both cerebral hemispheres (including frontal
and thalamic areas, the right posterior parietal region, and the
caudate head and lentiform nucleus), the brain stem, and
cerebellum. The cortical sulci were effaced, and the ventricular
system squeezed, secondary to mass effects of the lesions.
(B) Three slices of T2-weighted trans-axial images, with the same
positioning as Figure 1A, and revealing mixed-signal lesions and
associated perifocal edema.
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Discussion
In this report, we highlight a case of secondary mania,
which appeared to be the first symptom of AIDS, but
which, in fact, was the late phase of CNS HIV infection.
Manic syndrome affects approximately 8% of AIDS
patients, and generally occurs late in the course of HIV
disease.9 Lyketsos et al compared groups of patients
with HIV infection and mania according to whether
their first manic episode occurred when CD4 count
was less than 200/mm3 (late-onset mania) or at least
200/mm3 (early-onset mania).10 The late-onset patients
were less likely to have personal or family histories of
mood disorder and more likely to have dementia or
cognitive slowing.
Previous studies have tried to determine the
pathogenesis of HIV-related mania. Firstly, since HIV
preferentially affects subcortical gray matter such as
the caudate nuclei and cortical white matter, both of
which are important to the regulation of mood, manic
symptoms might indicate CNS HIV infection.11
Secondly, Dreyer et al reported that purified HIV coat
protein, gp 120, increased intraneuronal calcium in
vitro in a dose-dependent manner.12 HIV-related mania
may be caused by accumulation of intracellular free
calcium, which has been implicated in the patho-
genesis of bipolar disorder.13 Thirdly, el-Mallakh sug-
gested that mania or hypomania appeared to be
related to immunosuppression and progression of
HIV disease.14 Previous reports have also suggested
that manic or hypomanic symptoms are indicators of
poor outcome in AIDS.3,14 However, the underlying
mechanism is unclear. Our patient had no previous or
family history of mood disorders. He had a rapidly
downhill course from mania to depression, dementia,
and death within 10 months. Given the above find-
ings, our patient was more likely to have secondary
mania, and the clinical course was similar to that in
el-Mallakh’s report,14 in which nearly a quarter of
patients with AIDS-related mania died within 6 months
of the initial psychiatric presentation.
Also consistent with previous studies,14 the second-
ary manic syndrome in our case seemed to respond
adequately to pharmacotherapy (i.e. valproic acid and
lithium). However, patients with AIDS or CNS HIV
infection may be more prone to the adverse effects
of medication such as delirium, lithium toxicity, and
extrapyramidal symptoms.6,14 Similarly, our patient
experienced adverse effects, such as diarrhea, lower-
leg weakness, and hand tremor, even with a small
amount of mood stabilizers. These problems, accom-
panied by chest tightness, were also possibly due to
progression of HIV infection. Interestingly, in a 3-
year follow-up study, antiretroviral therapy demon-
strated protective efficacy against the development of
AIDS-related mania by halting HIV penetration into
the CNS.15 Unfortunately, the AIDS diagnosis in our
patient was not made until the late stage when HIV
infection was established in the CNS and the protective
effect of HAART had failed.
The next questions are: can HIV/AIDS be identi-
fied when masked by psychiatric symptoms; and can
the progression of HIV infection to AIDS be prevent-
ed? The answers to these questions are not definitive,
particularly in Taiwan, as clinician alertness to the
diagnosis of HIV/AIDS is still somewhat lacking. In
our case, the important information was not initially
discovered in the patient’s history. We did not know,
until the patient presented with disturbed conscious-
ness, and until AIDS was diagnosed, that the patient
had stayed in Africa, had been infected with malaria,
and had had a long-term sexual relationship with an
African woman. Furthermore, the patient’s hypersensi-
tivity to adverse effects, even with low doses of anti-
manic medications, may also have provided a clue as to
some type of CNS infection.
Progressive multifocal leukoencephalopathy (PML)
is considered an important differential diagnosis for
CNS complications of AIDS in many countries, in-
cluding Taiwan.16 The hallmark of PML in the brain is
patchy or confluent areas of low attenuation on CT
scan, or hyperintensity of T2-weighted images on
Figure 2. Magnetic resonance imaging scan after 4 months.
(A) Three slices of T1-weighted trans-axial images, with similar
parameters as in Figure 1A, showing obvious regression of the
mass effects after maturation of the abscess. The cortical sulci
and ventricular system were normalized. (B) Three slices of T2-
weighted trans-axial images, with the same positioning as Figure
2A, revealing conspicuous regression of the lesions and mass
effects.
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MRI scan. These lesions are generally not contrast-
enhancing and are not surrounded by edema. They are
usually bilateral, but asymmetric, and localized pref-
erentially to the periventricular areas and subcortical
white matter.17 The imaging findings in our case are
unlike those in PML. The multiple nodular lesions
with perifocal edema suggested the presence of
cerebritis and/or abscesses in both cerebral hemis-
pheres, mostly the cortical areas. However, the lesion
pathology could not be elicited because the family
refused a biopsy of the patient’s brain.
In Taiwan, although HIV/AIDS is not as common
as in the US, the gradually increasing prevalence
should make clinicians alert to the possibility of HIV/
AIDS as a differential diagnosis for bipolar disorder.
Previous studies have suggested that patients with
severe psychiatric illness have increased rates of HIV
infection.18,19 Cournos and McKinnon reported an
overall HIV infection rate of 7.8% among psychiatric
patients,18 compared with an estimated rate of 0.4% in
the general US population. High-risk behaviors,
especially intravenous drug abuse and unprotected
sex, are reported by 20–50% of psychiatric patients,
particularly those with schizophrenia or bipolar
disorder.19 Besides early detection of HIV infection,
managing psychiatric symptoms is particularly
important, since patients may actually spread HIV
through impulsivity6 or hypersexuality in the manic
phase.
Since the HIV/AIDS epidemic in Taiwan has pro-
gressed, we report this case to highlight the difficulties
in diagnosing AIDS masked by bipolar mania. Clinicians
should include HIV infection in the differential diag-
nosis of patients at high risk of such infection and who
present with mania. With earlier diagnosis and HAART,
patients may have the opportunity to live longer.
Psychiatric intervention can potentially alter the course
of HIV infection and improve patient quality of life.
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